In this presentation Dr. Joseph Raffaele recounts a pivotal conversation with Robert Butler, founder of the National Institute on Aging, who challenged him to quantify aging beyond patient-reported well‑being. This spurred a deep dive into molecular aging markers, especially telomeres and cellular senescence, and the inflammatory cascade driven by senescent cells. Dr. Raffaele describes a year‑long clinical cohort using the telomere‑activating supplement TA‑65, showing immune rejuvenation and robust biomarker modeling. He advocates estrogen replacement for perimenopausal women, refuting the myth that estrogen causes breast cancer, and highlights personalized interventions such as short meditation sessions paired with a neurofeedback head‑device that provides real‑time calm/active state feedback. A notable case is an 83‑year‑old Buddhist patient whose glycan‑age score is 37, illustrating the impact of combined hormonal, supplement, and biofeedback strategies. Finally, Dr. Raffaele emphasizes the convergence of high‑performance computing, artificial intelligence, and emerging aging science as the catalyst that will shift medicine from reactive disease treatment to proactive, individualized longevity management, urging listeners to engage with the evolving field.
Chapters
Robert Butler, who was the founder of the NIA, the National Institutes of Aging, called me one time in 2002 or so when I was about 5 years into my practice and asked me to come attend a roundtable of gerontologists, the scientists that study aging, to sort of see, you know, what it was I was doing in this new anti-aging medicine that had gotten publicity. I've been on NBC Today Show and some other national TV shows. Little did I know, I was sort of being brought in as a sacrificial lamb, somebody not necessarily doing what he should be doing. And, you know, there was a lot of criticism of some of our approach. But one thing that he did say to me is, you know, look, Joe, you seem like a pretty smart guy. You know, your patients are doing well, they feel well. And in fact, they did. And our practice was growing at that point. But he said, you call yourself an anti-aging physician. What are you actually doing to measure aging?. And I thought to myself, hmm, you know, uh, well, they feel good. So, but just like somebody that's treating high blood pressure, you know, how do you know if it's working until the person has a stroke? You don't know that it didn't work. So you have to measure the blood pressure. Well, you measure aging. And that started me on the journey that I'm still on and love, which is understanding and learning about biomarkers of aging. And how you have to, in order to really know whether something's doing something, you have to be able to measure it. You know, we have chromosomes in our cells that hold our DNA. It's all folded up into these neat little packages. In mammalian, DNA is linear, so it has ends to it. And that's a problem because DNA replication machinery, if it sees an end, it thinks it's a break in a chromosome and it starts to try to repair it. So the telomeres are these non-coding ends of the DNA that are repeats of the nucleotides TTA, GGG. They don't code for any proteins, so you don't lose anything when you lose them. And every time cells divide, they get a little bit shorter because the DNA polymerase, which is the enzyme that replicates DNA, can't replicate the ends of the chromosomes. So it's called the end replication problem in molecular biology. Then Cal Harley proposed the theory that it was the telomeres that were one of the major drivers of the aging process in cells. And so when they get critically short, they can't divide anymore. So for instance, your stem cells, which reside in every tissue in your body, those are there, very small percentage of the cells in, say, your liver or in your muscle, but they divide to replace degenerated cells that are cleaned up by your immune system. If they can't continue to do that, then they can't continue to, you know, regenerate those tissues, and that's a major aspect of the aging process. But not only do they not— they lose the ability to regenerate tissues, but once they become senescent, that's the term for a cell that can't divide anymore, they secrete these nasty inflammatory molecules called cytokines that we all sort of are familiar with now because of this cytokine storm from COVID And particularly immune systems, when they get into that— immune cells, when they get senescent, they start to secrete these inflammatory molecules that then not only make it a less effective immune system, but increase inflammation quite significantly. And we started this year-long cohort of patients that came through my practice and were on the protocol of supplements that we use and TA-65, that was called the patent protocol. We generated a lot of data from that and learned that TA-65, this molecule, was effective in rejuvenating the immune system. But we also looked at a whole bunch of other biomarkers at that time. And when we put them all together in an analysis, we found that it was a really good way to model the aging system. The future of medicine is to really get started early, see what is happening with your aging process, and then track it, treat, monitor, adjust. One of the successes that I see all the time in my practice is treating women who are perimenopausal or menopausal because estrogen is such an important molecule in them, getting rid of symptoms, I hear all the time from patients, "You gave me myself back." The worst advice I hear is, you mentioned it briefly, which is that estrogen causes breast cancer. It doesn't cause breast cancer. How can an endogenous molecule cause breast cancer? The associations have been looked at. The risk in the largest trial turned out to be non-statistically significant in younger women and clinically insignificant. So to stop all the benefits because of that makes no sense. And yet you still hear that because of the disinformation that's out there. And then taking that in the morning, some time to do a little 15 to 20 minute meditation, put a little device on your head, and then it tells you whether your mind is active, neutral, or calm, and it gives you immediate feedback into your ears as to which way you're going. And then you learn how to breathe into a calm state and you don't have to wonder whether you're in a calm state. It tells you. One of my patients is basically a Buddhist, and she sits for hours. She's 83. She's on a lot of hormones and other things too, but her glycan age is 37. So it definitely helps. We are in biomedical sciences, just like it was promised in 2000 when we sequenced the genome. We thought everything was going to change, but we needed to learn a few more things. But right now, with this convergence of computing power, artificial intelligence, and our understanding of the aging process, I really think that we are going to be altering the landscape of medicine, disease, how we think about, you know, healthy aging, like the internet revolution that took place, you know, in the late '90s, early 2000s. That was a seminal part of what changed the biomedical revolution. It was responsible for it. So, I think that, you know, you should really start to get involved in this. Go to some of those websites. Don't accept aging as, you know, the, you know, each year being able to do a little bit less, feel a little bit less well. That doesn't happen. You know, I'm almost 62. I want to keep on functioning like a 40-year-old. And the final word is that slowing aging is not a theoretical problem anymore. It's just a technological problem.
